Imaging Biometrics Ltd. (LON:IBAI)

Market Cap	1.76M
Revenue (ttm)	750.11K
Net Income (ttm)	-327.10K
Shares Out	246.71M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	376,002
Average Volume	337,117
Open	0.6700
Previous Close	0.6550
Day's Range	0.6700 - 0.6900
52-Week Range	0.6500 - 2.1000
Beta	2.62
RSI	39.91
Earnings Date	Aug 22, 2025

About Imaging Biometrics

Imaging Biometrics Ltd., through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, Switzerland, European Union, and the United States. It operates through Holding Company, Medical Software, and Oral Gallium Maltolate (GaM) segments. The company develops ready-to-use software applications for the healthcare industry comprising IB Clinic for all IB software platforms; IB Neuro, a MR DSC perfusion processing platform; IB Delta Suite, which creates Delta T1 maps from routin...

• Industry: Prepackaged Software
• Founded: 1965
• Employees: 7
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IBAI

Financial Performance

In 2024, Imaging Biometrics's revenue was 750,105, an increase of 23.09% compared to the previous year's 609,390. Losses were -327,103, -47.56% less than in 2023.